IPSC
IPSC
US15673T1007
Century Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
266.18M EUR
442.34M EUR
407.03M EUR
87.08M EUR
Enterprise Value
183.32M EUR
431.37M EUR
404.01M EUR
68.79M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-3.27x
--
--
--
Price to Sales
-
--
--
--
Price to Book
1.14x
1.9x
1.54x
0.55x
EV/Revenue
--
--
--
--
EV/EBITDA
-1.93x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-18.94%
-19.91%
-23.46%
-79.95%
ende